SEEL
SEEL Real Time Price USDRecent trades of SEEL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SEEL's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose Dec. 22, 2020
-
Patent Title: Compositions and methods for treating an aggregation disease or disorder Aug. 25, 2020
-
Patent Title: Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose Dec. 03, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SEEL in WallStreetBets Daily Discussion
Recent insights relating to SEEL
Recent picks made for SEEL stock on CNBC
ETFs with the largest estimated holdings in SEEL
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SEEL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.